tradingkey.logo
tradingkey.logo
Search

Stocks Quotes

Stock quotes focus on the U.S. market data, including indices, sectors, and related U.S. equity instruments.
US30
US30
US30
51731.200+0.01%
SPX500
SPX500
US500
7410.300-0.13%
NAS100
NAS100
NAS100
28398.700-0.63%

Distribution

Latest
History
No Data

Sector

View More

Industrial Goods

+2.80%
Lockheed Martin Corp+10.41%
Unusual Machines Inc+9.71%
Rectitude Holdings Ltd+9.24%

Pharmaceuticals & Medical Research

+1.13%
Zhengye Biotechnology Holding Ltd+27.69%
Neuphoria Therapeutics Inc+16.82%
Scisparc Ltd+16.22%

Investment Holding Companies

+1.12%
SUNB.NB+6.96%
Miluna Acquisition Units+6.48%
Inflection Point Acquisition IV Ord Shs Class A+5.70%

Energy - Fossil Fuels

+1.03%
Vivakor Inc+28.22%
Robin Energy Ltd+26.91%
TMD Energy Ltd+18.60%

Utilities

+0.99%
Sunation Energy Inc+10.17%
SolarMax Technology Inc+6.33%
Ge Vernova Inc+4.83%

Healthcare Services & Equipment

+0.91%
Advanced Biomed Inc+36.49%
Novocure Ltd+28.39%
Acme United Corp+13.57%
No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
4111
QDRO Acquisition Units (Proposed)
QDRO Acquisition Units (Proposed)
QADRU
10.080
0.000
0.00%
--
0.00
0.00
252.00M
25.00M
0.00
0.18
0.000
0.000
0.00
0.00
-0.10%
+0.00%
-0.10%
+1.46%
--
--
--
4112
SC II Acquisition Units
SC II Acquisition Units
SCIIU
10.220
0.000
0.00%
--
0.00
0.00
251.22M
24.90M
0.49
38.02
11.295
10.030
0.00
0.00
+3.30%
+0.39%
+0.30%
+0.00%
+0.20%
--
+1.49%
4113
SC II Acquisition Rights Exp 26 Nov 2030
SC II Acquisition Rights Exp 26 Nov 2030
SCIIR
0.192
0.000
0.00%
--
0.00
0.00
251.22M
0.00
5.66
6.42
0.300
0.200
0.00
0.00
-5.96%
+13.77%
-2.06%
-16.70%
-34.48%
--
--
4114
Profound Medical Corp
Profound Medical Corp
PROF
6.920
-0.070
-1.00%
6.04
13.51K
65.94K
251.15M
36.29M
2.50
0.30
12.400
5.230
0.00
0.00
+2.06%
-5.59%
+6.30%
+2.52%
-7.49%
+17.29%
-12.07%
4115
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
FULC
3.770
+0.070
+1.89%
5.92
830.09K
2.08M
251.00M
66.58M
4.09
0.47
15.740
5.880
0.00
0.00
+7.71%
+5.01%
+0.27%
-51.17%
-65.54%
-51.79%
-66.67%
4116
SC II Acquisition Ord Shs Class A
SC II Acquisition Ord Shs Class A
SCII
10.080
-0.010
-0.10%
--
61.18K
617.28K
250.97M
24.90M
0.09
4.10
10.070
9.900
0.00
0.00
-0.10%
+0.15%
+0.30%
+0.90%
+1.46%
--
--
4117
Ares Commercial Real Estate Corp
Ares Commercial Real Estate Corp
ACRE
4.530
-0.040
-0.88%
5.61
306.08K
501.01K
250.82M
55.37M
1.53
0.82
5.890
4.050
0.60
13.24
-3.62%
+2.26%
+1.34%
-15.01%
-12.72%
-1.31%
-5.23%
4118
1-800-Flowers.Com Inc
1-800-Flowers.Com Inc
FLWS
3.910
-0.300
-7.13%
6.43
630.37K
1.73M
250.57M
64.09M
10.68
2.69
8.440
2.885
0.00
0.00
-4.17%
+2.89%
+7.71%
+3.17%
-15.55%
-37.54%
-0.51%
4119
Vista Gold Corp
Vista Gold Corp
VGZ
1.715
-0.025
-1.44%
5.74
920.09K
807.37K
250.34M
145.97M
4.59
0.60
3.130
0.910
0.00
0.00
+10.65%
-3.65%
-10.68%
-22.05%
-37.86%
+80.56%
-12.94%
4120
Amtech Systems Inc
Amtech Systems Inc
ASYS
17.230
-0.110
-0.63%
6.70
255.59K
3.32M
249.78M
14.50M
4.12
0.75
24.000
3.850
0.00
0.00
+3.11%
-7.71%
-11.78%
-2.82%
-0.92%
+266.60%
+37.29%
4121
Launch Two Acquisition Corp
Launch Two Acquisition Corp
LPBBU
10.860
0.000
0.00%
--
0.00
0.00
249.78M
28.75M
0.00
9.67
11.670
10.094
0.00
0.00
-0.37%
-0.09%
+1.21%
+6.19%
--
+1.63%
--
4122
Artiva Biotherapeutics Inc
Artiva Biotherapeutics Inc
ARTV
10.105
+0.085
+0.85%
5.66
255.41K
1.78M
249.76M
24.72M
8.48
0.59
14.530
1.470
0.00
0.00
+11.78%
+7.39%
+8.42%
-6.00%
+143.49%
+193.75%
+135.55%
4123
Overseas Shipholding Group Ord Shs Class A
Overseas Shipholding Group Ord Shs Class A
OSG
5.535
-0.305
-5.22%
5.08
375.86K
1.09M
249.15M
45.01M
4.79
1.19
10.380
3.880
0.00
0.00
-9.26%
-8.96%
-14.45%
+22.19%
-2.72%
-35.79%
-28.86%
4124
QDRO Acquisition Ord Shs Class A
QDRO Acquisition Ord Shs Class A
QADR
9.955
+0.035
+0.35%
--
51.61K
510.23K
248.88M
25.00M
1.71
2.64
10.790
9.850
0.00
0.00
+0.05%
-0.15%
+0.30%
--
--
--
--
4125
Wilco 63 Units
Wilco 63 Units
WLCOU
9.950
0.000
0.00%
--
85.00
846.00
248.75M
25.00M
0.00
0.01
9.970
9.910
0.00
0.00
+0.22%
-0.50%
+0.25%
--
--
--
--
4126
Cambridge Acquisition Units (Proposed)
Cambridge Acquisition Units (Proposed)
CAQUU
10.010
-0.040
-0.40%
--
330.00
3.30K
248.66M
0.00
0.00
0.39
10.020
9.900
0.00
0.00
+0.30%
-0.10%
+0.10%
+0.70%
--
--
--
4127
Cambridge Acquisition Ord Shs Class A
Cambridge Acquisition Ord Shs Class A
CAQ
9.940
+0.030
+0.30%
--
7.00
69.00
248.66M
31.16M
0.00
0.00
10.100
9.800
0.00
0.00
+0.30%
+0.10%
+0.30%
+0.40%
--
--
--
4128
Copley Acquisition Corp
Copley Acquisition Corp
COPL
10.460
+0.020
+0.19%
--
102.11K
807.39K
248.20M
23.73M
0.38
1.11
10.690
9.980
0.00
0.00
+0.10%
+0.00%
+0.34%
+0.97%
+1.95%
+3.71%
+1.95%
4129
Thayer Ventures Acquisition II Corp
Thayer Ventures Acquisition II Corp
TVAIU
10.470
-0.180
-1.69%
--
2.00
21.00
248.10M
23.70M
0.00
0.02
14.650
10.020
0.00
0.00
+0.48%
+0.76%
-0.10%
-0.76%
+1.16%
+3.66%
+1.55%
4130
Mckinley Acquisition Ord Shs Class A
Mckinley Acquisition Ord Shs Class A
MKLY
10.190
+0.010
+0.10%
--
698.00
5.05K
248.07M
24.34M
0.19
0.05
10.190
9.850
0.00
0.00
+0.00%
+0.30%
+0.30%
+0.86%
+1.60%
--
+2.21%
4131
McKinley Acquisition Rights
McKinley Acquisition Rights
MKLYR
0.210
0.000
0.00%
--
0.00
0.00
247.83M
0.00
14.95
6.12
0.422
0.100
0.00
0.00
-9.98%
+2.17%
-4.35%
+107.92%
+40.00%
--
+61.66%
4132
Copley Acquisition Units
Copley Acquisition Units
COPL_u
10.590
+0.080
+0.76%
--
107.00
1.06K
247.72M
0.00
0.00
0.40
12.070
10.000
0.00
0.00
--
--
--
--
--
+4.85%
+2.22%
4133
JJill Inc
JJill Inc
JILL
16.555
-0.145
-0.87%
6.44
78.81K
519.55K
247.52M
14.95M
2.96
0.75
18.800
10.405
0.32
1.93
-1.52%
+4.58%
+10.59%
+29.34%
+4.98%
+1.19%
+20.66%
4134
Rithm Acquisition Units
Rithm Acquisition Units
RAC_u
10.910
0.000
0.00%
--
0.00
0.00
247.48M
0.00
0.00
0.00
10.900
10.000
0.00
0.00
+0.94%
--
-0.56%
+0.38%
--
+1.96%
--
4135
Prelude Therapeutics Inc
Prelude Therapeutics Inc
PRLD
3.925
0.000
0.00%
5.83
205.87K
523.44K
247.09M
62.95M
4.68
0.86
5.540
0.750
0.00
0.00
-6.10%
-20.06%
-8.08%
-13.16%
+106.58%
+330.37%
+35.34%
4136
Palladyne AI Corp
Palladyne AI Corp
PDYN
5.230
-0.100
-1.88%
6.34
709.32K
2.71M
247.09M
47.24M
6.28
0.80
13.000
4.140
0.00
0.00
+7.84%
-4.21%
-12.54%
-16.19%
-25.29%
-49.47%
+22.77%
4137
Dynamix Corp
Dynamix Corp
DYNX
11.160
0.000
0.00%
--
0.00
0.00
247.01M
22.13M
3.65
1.36
15.240
9.780
0.00
0.00
+5.18%
-0.45%
+3.33%
+10.93%
+12.90%
--
+13.99%
4138
Kingsway Ord Shs
Kingsway Ord Shs
KWY
8.625
-0.365
-4.06%
--
143.71K
504.75K
246.90M
28.63M
5.56
2.22
16.795
9.800
0.00
0.00
-10.62%
-13.66%
-18.56%
--
--
--
--
4139
Citizens Inc
Citizens Inc
CIA
4.895
-0.205
-4.02%
3.97
100.35K
187.78K
246.39M
50.33M
6.76
0.97
6.404
3.245
0.00
0.00
-10.18%
-12.43%
-16.47%
-12.90%
-11.80%
+17.11%
+1.35%
4140
Ready Capital Corp
Ready Capital Corp
RC
1.490
-0.030
-1.97%
6.50
1.23M
733.22K
246.23M
165.26M
2.63
0.92
4.750
1.500
1.56
104.86
-9.15%
-12.35%
-12.87%
-20.32%
-32.58%
-66.52%
-31.65%

Stock Analysis

Intel Q2 Earnings Far Exceed Expectations: 59% Data Center Business Growth, CPUs Becoming AI Era Protagonists Again

TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

TradingKeyan hour ago
TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKey2 hours ago
TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

Micron (MU) Hits $1,000 on Three Catalysts - Google Capex, Vera Rubin, NAND Shortage

TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

TradingKey4 hours ago
TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

Japan and South Korea Stocks Open Lower, KOSPI Drops Over 3%, SoftBank Falls Over 5%, SK Hynix and Kioxia Fall Nearly 4%

TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

TradingKey4 hours ago
TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

Today’s Market Recap: Oil Breaks $100, Fueling Inflation Fears, as AI Capex Faces Scrutiny and Tesla’s 14% Plunge Drags Down Tech Sector

TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

TradingKey4 hours ago
TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

Intel Q2 Net Profit Swings to Profit YoY, Adjusted EPS Doubles Estimates: Revenue Up 25%, After-Hours Shares Rise Over 13%

Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey8 hours ago
Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey SmartPicks

Upcoming Events

Earnings

Dividends

Stock Splits

IPO

Market Heatmap

Stocks

Sector

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.